Associated Papers
CYYR1 promotes the degradation of the E3 ubiquitin ligase WWP1 and is associated with favorable prognosis in breast cancer.
Perron T et al.
The Journal of Biological Chemistry, 2024
The Penta-EF-Hand ALG-2 Protein Interacts with the Cytosolic Domain of the SOCE Regulator SARAF and Interferes with Ubiquitination.
Zhang W et al.
International Journal of Molecular Sciences, 2020
Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway.
Lee YR et al.
Science (new York, N.y.), 2019
Functional Characterization of a WWP1/Tiul1 Tumor-derived Mutant Reveals a Paradigm of Its Constitutive Activation in Human Cancer.
Courivaud T et al.
The Journal of Biological Chemistry, 2015
Ezrin ubiquitylation by the E3 ubiquitin ligase, WWP1, and consequent regulation of hepatocyte growth factor receptor activity.
Zaarour RF et al.
Plos One, 2012
The E3 ubiquitin ligase WWP1 regulates ΔNp63-dependent transcription through Lys63 linkages.
Peschiaroli A et al.
Biochemical and Biophysical Research Communications, 2010
WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer.
Li Y et al.
Oncogene, 2009
WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.
Li Y et al.
Cell Death and Differentiation, 2008
The Nedd4-like family of E3 ubiquitin ligases and cancer.
Chen C et al.
Cancer Metastasis Reviews, 2007
Select a paper to view details